Tevogen Bio Holdings Inc

Research Tevogen Bio Holdings Inc (TVGN) on Bullrun: market cap USD 26.34M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerTVGN
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 26.34M
• Financial periodFY2025
• Net income-USD 26.28M
• Free cash flow-USD 12.39M

Valuation Snapshot

latest market cap is USD 26.34M.

About Tevogen Bio Holdings Inc

Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients;

Frequently asked questions

What is Tevogen Bio Holdings Inc's market cap?

Tevogen Bio Holdings Inc's market capitalization is USD 26.34M.

What does Tevogen Bio Holdings Inc do?

Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.